Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2010Molecular Cancer TherapeuticsOpen Access

Glioblastoma Cancer-Initiating Cells Inhibit T-Cell Proliferation and Effector Responses by the Signal Transducers and Activators of Transcription 3 Pathway

View Full Paper
Ask AI
Bookmark
Share

Authors

JWJun WeiThe University of Texas MD Anderson Cancer CenterJBJason BarrThe University of Texas MD Anderson Cancer CenterLKLing-Yuan KongCleveland Clinic

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wei et al. (2010) studied this question.

synapsesocial.com/papers/6a1257e6a4bed3c7b166effdhttps://doi.org/10.1158/1535-7163.mct-09-0734
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.1984 · 369 citations
  2. 2Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors.1984 · 106 citations
  3. 3A Selective Impairment of the IL-2 System in Lymphocytes of Patients with Glioblastomas: Increased Level of Soluble IL-2R and Reduced Protein Tyrosine Phosphorylation1997 · 34 citations